NASDAQ:LBRX | Free Cash Flow | LB PHARMACEUTICALS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2024-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$23.29M$32,000.00-$23.32M
2025-12-31-$18.1M$40,000.00-$18.14M
2025-03-31-$8.13M$21,000.00-$8.15M
2024-12-31-$5.67M$238,000.00-$5.9M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$35.21M$52,000.00-$35.26M
2024-12-31-$53.05M$769,000.00-$53.82M